39 results
8-K
ZYNE
Zynerba Pharmaceuticals, Inc.
15 Oct 20
Other Events
4:15pm
Biomarker,” at the Joint 16th International Child Neurology Congress (ICNC) & 49th Annual Child Neurology Society (CNS) Meeting. Data from … Neurology Congress (ICNC) and 49th Annual Child Neurology Society (CNS) Meeting. Data from this poster will also be presented as an oral presentation during
8-K
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
9 Sep 21
Other Events
7:10am
Disorder (ASD) at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021
DEVON, Pa., September 9, 2021 – Zynerba Pharmaceuticals … as an oral presentation at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021 being held virtually from September 9-10, 2021
8-K
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
15 Oct 20
Other Events
4:15pm
Joint 16th International Child Neurology Congress (ICNC)
& 49th Annual Child Neurology Society (CNS) Meeting
DEVON, Pa., October 15, 2020 – Zynerba … Annual Child Neurology Society (CNS) Meeting. These data will also be presented as an oral presentation during the “Research Pipeline: New Findings
8-K
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
10 Mar 20
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
7:16am
and Other Pediatric Disorders Presented at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Meeting
An HUI specific to FXS, known … ’ Perspectives on FXS Diagnosis and Patient Journey Perspective Presented at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Meeting
8-K
EX-99.1
ZYNE
Zynerba Pharmaceuticals, Inc.
1 Jun 22
Zynerba Pharmaceuticals Presents Data on Zygel™ at the American Society of Clinical Psychopharmacology Annual Meeting
7:06am
Exhibit 99.1
Zynerba Pharmaceuticals Presents Data on Zygel™ at the American Society of Clinical Psychopharmacology Annual Meeting
– Poster … an oral podium presentation and a poster presentation at the American Society of Clinical Psychopharmacology Annual Meeting (ASCP 2022), being held May
8-K
EX-99.2
830pya2d
15 Oct 20
Other Events
4:15pm
8-K
EX-99.1
sv7y5o yf3glykbpz0q
9 Aug 21
Zynerba Pharmaceuticals Reports Second Quarter 2021 Financial Results
7:06am
8-K
EX-99.2
lbgcw 895usw
3 Mar 20
Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers
12:15pm
8-K
EX-99.1
xbxc6bab2ntqatj xy
4 Dec 20
Other Events
12:30pm
8-K
EX-99.2
cq4g7viz4e
9 Nov 20
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results
7:16am
8-K
EX-99.1
n5u562nasdy1kmafgb
16 May 22
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results
7:10am
8-K
EX-99.1
kf04ipqc0o
10 Aug 22
Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
12:00am
8-K
EX-99.1
kdxne73rx
9 Nov 20
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results
7:16am
8-K
EX-99.1
gsbcogw0o041f y4vl
3 Mar 20
Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers
12:15pm
8-K
n042 q8bdw8cbm8rc6
1 Jun 22
Zynerba Pharmaceuticals Presents Data on Zygel™ at the American Society of Clinical Psychopharmacology Annual Meeting
7:06am
8-K
4v4kw sgmfi
4 Dec 20
Other Events
12:30pm
8-K
p2h4e o38u7lx
3 Mar 20
Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers
12:15pm
8-K
EX-99.1
55dp52ha
15 Apr 20
Other Events
7:30am
8-K
EX-99.2
qttm249ug 6hh
10 Mar 20
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
7:16am
8-K
EX-99.2
td91xxr y9lh8sf1v3ih
11 May 20
Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results
7:00am